Treatment of Experimental Viral Myocarditis With Interleukin-10
Author(s) -
Ryosuke Nishio,
Akira Matsumori,
Tetsuo Shioi,
Hiroshi Ishida,
Shigetake Sasayama
Publication year - 1999
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.100.10.1102
Subject(s) - medicine , myocarditis , viral myocarditis , cytokine , virus , tumor necrosis factor alpha , interleukin , in vivo , histopathology , immunology , nitric oxide synthase , nitric oxide , pathology , biology , microbiology and biotechnology
The T helper cell type 2-associated cytokine interleukin (IL)-10 has a variety of immunomodulatory properties. However, the effects of the cytokine on viral myocarditis remain unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom